SORT1 and essential thrombocythemia: A highly significant reduction of mRNA and sortilin expression levels was observed in mutant cells when compared with their wild-type counterparts (Figure 3(a) and (b)), suggesting that the SORT1 p.G171A mutation identified in our ET patients is implicated in sortilin dysregulation.